|
|
ASH 2005 Webcast - Update On The Velcade APEX Trial For Relapsed Patients
By Dr. Paul Richardson
Dana Farber Cancer Institute
|
|
High-Dose Melphalan in the Era of New Effective Agents
The Potential Role of Novel Combinations in Frontline Therapy
The Importance of Achieving Complete Remission (CR)
Does the Percentage of Complete Response with New Drugs Determine Ultimate Survival?
The Safety Issue Surrounding Maintenance Therapy
Does Maintenance Therapy Improve Time to Progression and Ultimate Survival?
Is Double Transplant Better Than Single Transplant?
Tandem vs Single Transplant: Which is Better for Whom?
Role of New Drug Trials at Relapse
What is role of high-dose melphalan in the era of new effective agents?
|
|
|
Bart Barlogie, MD
University of Arkansas for Medical Sciences
Myeloma Institute for Research and Therapy
Little Rock, Arkansas
|
|
|
|
|
Brian G.M. Durie, MD
Cedars Sinai Comprehensive Cancer Center
Los Angeles, California
|
|
Does the percentage of complete response with new drugs determine ultimate survival?
|
|
|
James D. Cavenagh, MD, MRCP
St. Bartholomew's Hospital
London, England
|
|
|
|
|
Jean-Luc Harousseau, MD
University Hospital Nantes
Nantes, France
|
|
Does maintenance improve time to progression and ultimate survival?
|
|
|
Antonio Palumbo, MD
Molinette Hospital
Turin, Italy
|
|
|
|
|
James D. Cavenagh, MD MRCP
St. Bartholomew's Hospital
London, England
|
|
Is double transplant better than single transplant?
|
|
|
Jean-Luc Harousseau, MD
University Hospital Nantes
Nantes, France
|
|
|
|
|
Bart Barlogie, MD
University of Arkansas for Medical Sciences
Myeloma Institute for Research and Therapy
Little Rock, Arkansas
|
|
Should known effective therapies or new agents be used in patients with relapsed disease?
|
|
|
|
Brian G.M. Durie, MD
Cedars Sinai Comprehensive Cancer Center
Los Angeles, California
|
|
|
|
|
|
The IMF is pleased to provide you with a broad sampling of myeloma presentations and posters from the 2005 annual meeting of the American Society of Hematology in San Diego, California. We hope you will find this material informative and useful. |
|
|
print
related articles